October 19, 2021

Now available UPLIZNA®

UPLIZNA® (inebilizumab-cdon) injection, for intravenous use, is indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive. Hepatitis B Virus Screening Prior to initiating UPLIZNA, perform Hepatitis B virus (HBV) screening.

Please see full prescribing information.